Grown Rogue International (GRUSF) Assets Average (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Assets Average came in at $64.3 million in Q1 2026, down 100.0% quarter-over-quarter from $27951.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Assets Average (2009 - 2026) Analysis & Trends
Grown Rogue International's Assets Average history runs 17 years deep, the most recent figure standing at $64.3 million for Q1 2026.
- On a quarterly basis, Assets Average changed N/A year-over-year to $64.3 million in Q1 2026; TTM through Mar 2026 was $64.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $54.2 million, up 60.81% from the prior year.
- Assets Average fell to $64.3 million in Q1 2026 per GRUSF's latest filing, from $27951.3 billion in the prior quarter.
- Across five years, Assets Average topped out at $51990.5 billion in Q3 2025 and bottomed at $19.0 million in Q2 2023.
- The 4-year median for Assets Average is $48.9 million (2024), against an average of $12997.7 billion.
- Biggest YoY gain for Assets Average was 177926863.05% in 2025; the steepest drop was 71923481.99% in 2025.
- Year by year, Assets Average stood at $19.0 million in 2023, then soared by 53.9% to $29.2 million in 2024, then surged by 95657457.56% to $27951.3 billion in 2025, then plunged by 100.0% to $64.3 million in 2026.
- Per Business Quant, the three latest GRUSF Assets Average figures stand at $64.3 million (Q1 2026), $27951.3 billion (Q4 2025), and $51990.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 64.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.29 Mn |
| Dec 31, 2025 | 27,951.27 Bn |
| Sep 30, 2025 | 51,990.50 Bn |
| Jun 30, 2025 | 24,039.29 Bn |
| Sep 30, 2024 | 29.22 Mn |
| Jun 30, 2024 | 33.42 Mn |
| Mar 31, 2024 | 30.23 Mn |
| Apr 30, 2023 | 18.99 Mn |
| Apr 30, 2021 | 7.20 Mn |
| Jan 31, 2021 | 4.73 Mn |
| Oct 31, 2020 | 3.90 Mn |
| Jul 31, 2020 | 3.92 Mn |
| Apr 30, 2020 | 3.48 Mn |
| Jan 31, 2020 | 3.05 Mn |
| Jan 31, 2019 | 5.94 Mn |
| Oct 31, 2018 | 2.70 Mn |
| Nov 30, 2017 | 1.48 Mn |
| Oct 31, 2017 | 1.47 Mn |
| Aug 31, 2017 | 61,408.40 |
| May 31, 2017 | 91,160.85 |